Ozelar®

Ozelar® is caffeine citrate, the gold standard of treatment for primary apnea in premature newborns.

In apnea in premature newborns, Ozelar® stimulates the central nervous system (CNS) via several mechanisms:

  • stimulation of respiratory centers;
  • increased minute ventilation;
  • reduced threshold of carbon dioxide level in blood;
  • increased response to the carbon dioxide level in blood;
  • increased muscle tone;
  • reduced diaphragm fatigue;
  • increased rate of metabolism;
  • increased oxygen consumption.

Indications:

Treatment of primary apnea in premature newborns.

Presentation:

Solution for infusion and oral use.

One mL in ampoules No.10; 5 ampoules per blister; 2 blisters in a carton.

Method of administration:

Intravenous, oral.

Age:

May be used in premature newborns.

How supplied
1 ml
Sales markets

Ukraine